Lv1
20 积分 2026-04-27 加入
Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
7天前
已完结
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies
16天前
已完结
Toward the Development of a Manufacturing Process for Milvexian: Scale-Up Synthesis of the Side Chain
16天前
已完结